CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 175 of 277 entries

View as:

Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia A

Phase: N/A Priority: Normal

NCT ID: NCT00306670 Org: User:

Start: 04/30/06 End: 08/31/11 Due: 08/31/12

Improving Genetic Counseling for BRCA+ Mothers

Phase: N/A Priority: Normal

NCT ID: NCT04258280 Org: User:

Start: 07/01/20 End: 12/31/25 Due: 12/31/26

Acute Stroke Program of Interventions Addressing Racial and Ethnic Disparities

Phase: N/A Priority: Normal

NCT ID: NCT00724555 Org: User:

Start: 02/29/08 End: 01/31/13 Due: 01/31/14

Rehabilitation and Prophylaxis of Anomia in Primary Progressive Aphasia

Phase: N/A Priority: Normal

NCT ID: NCT02675270 Org: User:

Start: 11/30/11 End: 06/30/24 Due: 06/30/25

A Study of the Effects of PEITC on Oral Cells With Mutant p53

Phase: N/A Priority: Normal

NCT ID: NCT01790204 Org: User:

Start: 02/29/12 End: 04/30/14 Due: 04/30/15

Evaluating the Outcomes for Incisional Application of Negative Pressure for Nontraumatic Amputations

Phase: N/A Priority: Normal

NCT ID: NCT03250442 Org: User:

Start: 11/01/17 End: 09/30/21 Due: 09/30/22

Glucose-Guided Eating Pilot

Phase: N/A Priority: Normal

NCT ID: NCT05998460 Org: User:

Start: 01/02/24 End: 08/31/25 Due: 08/31/26

Use of Pharmacogenetics to Select Erbitux or Cisplatin to Treat Head and Neck Cancer

Phase: N/A Priority: Normal

NCT ID: NCT01790516 Org: User:

Start: 05/31/12 End: 06/30/13 Due: 06/30/14

Outcomes for 2 Operations Versus ≥ 3 Operations in Infected Wounds

Phase: N/A Priority: Normal

NCT ID: NCT02559453 Org: User:

Start: 09/30/15 End: 06/30/20 Due: 06/30/21

Post-Mastectomy Analgesia Using Exparel (Liposomal) Versus Standard Bupivacaine or Placebo

Phase: N/A Priority: Normal

NCT ID: NCT03504865 Org: User:

Start: 07/01/19 End: 12/31/21 Due: 12/31/22

OXEL: Immune Checkpoint or Capecitabine or Combination Therapy as Adjuvant Therapy for TNBC With Residual Disease

Phase: N/A Priority: Normal

NCT ID: NCT03487666 Org: User:

Start: 05/21/18 End: 05/02/24 Due: 05/02/25

Januvia (Sitagliptin) in Healing Chronic Diabetic Foot Ulcers

Phase: N/A Priority: Normal

NCT ID: NCT02015910 Org: User:

Start: 01/31/14 End: 01/31/15 Due: 01/31/16

Testing a Culturally Adapted Telephone Genetic Counseling Intervention

Phase: N/A Priority: Normal

NCT ID: NCT03959267 Org: User:

Start: 07/07/17 End: 01/30/21 Due: 01/30/22

Vascular Sealant Study

Phase: N/A Priority: Normal

NCT ID: NCT00618358 Org: User:

Start: 03/31/07 End: - Due: -

A Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients

Phase: N/A Priority: Normal

NCT ID: NCT05479045 Org: User:

Start: 01/31/25 End: 11/30/26 Due: 11/30/27

Placebo Controlled Trial of Bosentan in Scleroderma Patients

Phase: N/A Priority: Normal

NCT ID: NCT00377455 Org: User:

Start: 09/30/06 End: 03/31/10 Due: 03/31/11

Study of Gulf War Illness (GWI) by Comparing GWI and Healthy Veterans

Phase: N/A Priority: Normal

NCT ID: NCT00810225 Org: User:

Start: 08/31/08 End: 07/31/11 Due: 07/31/12

Exergaming Intervention and Breast Cancer Biomarkers in Black Women

Phase: N/A Priority: Normal

NCT ID: NCT02152462 Org: User:

Start: 12/31/12 End: 12/31/19 Due: 12/31/20

Daratumumab for Polyneuropathy Associated With MGUS

Phase: N/A Priority: Normal

NCT ID: NCT06046287 Org: User:

Start: 07/31/25 End: 12/31/26 Due: 12/31/27

Albumin for Intracerebral Hemorrhage Intervention

Phase: N/A Priority: Normal

NCT ID: NCT00990509 Org: User:

Start: 09/30/09 End: 06/30/13 Due: 06/30/14

Study on Effective Mydriasis in Premature Infants

Phase: N/A Priority: Normal

NCT ID: NCT01054027 Org: User:

Start: 03/31/07 End: 03/31/08 Due: 03/31/09

Genetic Testing in Predicting Response to Paclitaxel in Women With Breast Cancer

Phase: N/A Priority: Normal

NCT ID: NCT00088829 Org: User:

Start: 04/30/01 End: 12/31/12 Due: 12/31/13

ABT-888 and Temozolomide for Liver Cancer

Phase: N/A Priority: Normal

NCT ID: NCT01205828 Org: User:

Start: 08/31/10 End: 10/31/14 Due: 10/31/15

Outcomes of Post-operative Diet in Children Following Tonsillectomy and Adenoidectomy

Phase: N/A Priority: Normal

NCT ID: NCT03437954 Org: User:

Start: 12/15/17 End: 12/31/19 Due: 12/31/20

Evaluating Blood Glucose Levels During Infusion With HepaGam B (HBIG) in Post-liver Transplant Patients

Phase: N/A Priority: Normal

NCT ID: NCT00998426 Org: User:

Start: 10/31/09 End: 12/31/11 Due: 12/31/12

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia A	NCT00306670	Georgetown University	user2@example.com	None	2006-04-30	2011-08-31	2012-08-31	-	-	2025-07-14
Improving Genetic Counseling for BRCA+ Mothers	NCT04258280	Georgetown University	user2@example.com	None	2020-07-01	2025-12-31	2026-12-31	-	-	2025-07-14
Acute Stroke Program of Interventions Addressing Racial and Ethnic Disparities	NCT00724555	Georgetown University	user2@example.com	None	2008-02-29	2013-01-31	2014-01-31	-	-	2025-07-14
Rehabilitation and Prophylaxis of Anomia in Primary Progressive Aphasia	NCT02675270	Georgetown University	user2@example.com	None	2011-11-30	2024-06-30	2025-06-30	-	-	2025-07-14
A Study of the Effects of PEITC on Oral Cells With Mutant p53	NCT01790204	Georgetown University	user2@example.com	None	2012-02-29	2014-04-30	2015-04-30	-	-	2025-07-14
Evaluating the Outcomes for Incisional Application of Negative Pressure for Nontraumatic Amputations	NCT03250442	Georgetown University	user2@example.com	None	2017-11-01	2021-09-30	2022-09-30	-	-	2025-07-14
Glucose-Guided Eating Pilot	NCT05998460	Georgetown University	user2@example.com	None	2024-01-02	2025-08-31	2026-08-31	-	-	2025-07-14
Use of Pharmacogenetics to Select Erbitux or Cisplatin to Treat Head and Neck Cancer	NCT01790516	Georgetown University	user2@example.com	None	2012-05-31	2013-06-30	2014-06-30	-	-	2025-07-14
Outcomes for 2 Operations Versus ≥ 3 Operations in Infected Wounds	NCT02559453	Georgetown University	user2@example.com	None	2015-09-30	2020-06-30	2021-06-30	-	-	2025-07-14
Post-Mastectomy Analgesia Using Exparel (Liposomal) Versus Standard Bupivacaine or Placebo	NCT03504865	Georgetown University	user2@example.com	None	2019-07-01	2021-12-31	2022-12-31	-	-	2025-07-14
OXEL: Immune Checkpoint or Capecitabine or Combination Therapy as Adjuvant Therapy for TNBC With Residual Disease	NCT03487666	Georgetown University	user2@example.com	None	2018-05-21	2024-05-02	2025-05-02	-	-	2025-07-14
Januvia (Sitagliptin) in Healing Chronic Diabetic Foot Ulcers	NCT02015910	Georgetown University	user2@example.com	None	2014-01-31	2015-01-31	2016-01-31	-	-	2025-07-14
Testing a Culturally Adapted Telephone Genetic Counseling Intervention	NCT03959267	Georgetown University	user2@example.com	None	2017-07-07	2021-01-30	2022-01-30	-	-	2025-07-14
Vascular Sealant Study	NCT00618358	Georgetown University	user2@example.com	None	2007-03-31	-	-	-	-	2025-07-14
A Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients	NCT05479045	Georgetown University	user2@example.com	None	2025-01-31	2026-11-30	2027-11-30	-	-	2025-07-14
Placebo Controlled Trial of Bosentan in Scleroderma Patients	NCT00377455	Georgetown University	user2@example.com	None	2006-09-30	2010-03-31	2011-03-31	-	-	2025-07-14
Study of Gulf War Illness (GWI) by Comparing GWI and Healthy Veterans	NCT00810225	Georgetown University	user2@example.com	None	2008-08-31	2011-07-31	2012-07-31	-	-	2025-07-14
Exergaming Intervention and Breast Cancer Biomarkers in Black Women	NCT02152462	Georgetown University	user2@example.com	None	2012-12-31	2019-12-31	2020-12-31	-	-	2025-07-14
Daratumumab for Polyneuropathy Associated With MGUS	NCT06046287	Georgetown University	user2@example.com	None	2025-07-31	2026-12-31	2027-12-31	-	-	2025-07-14
Albumin for Intracerebral Hemorrhage Intervention	NCT00990509	Georgetown University	user2@example.com	None	2009-09-30	2013-06-30	2014-06-30	-	-	2025-07-14
Study on Effective Mydriasis in Premature Infants	NCT01054027	Georgetown University	user2@example.com	None	2007-03-31	2008-03-31	2009-03-31	-	-	2025-07-14
Genetic Testing in Predicting Response to Paclitaxel in Women With Breast Cancer	NCT00088829	Georgetown University	user2@example.com	None	2001-04-30	2012-12-31	2013-12-31	-	-	2025-07-14
ABT-888 and Temozolomide for Liver Cancer	NCT01205828	Georgetown University	user2@example.com	None	2010-08-31	2014-10-31	2015-10-31	-	-	2025-07-14
Outcomes of Post-operative Diet in Children Following Tonsillectomy and Adenoidectomy	NCT03437954	Georgetown University	user2@example.com	None	2017-12-15	2019-12-31	2020-12-31	-	-	2025-07-14
Evaluating Blood Glucose Levels During Infusion With HepaGam B (HBIG) in Post-liver Transplant Patients	NCT00998426	Georgetown University	user2@example.com	None	2009-10-31	2011-12-31	2012-12-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance